COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study – Science Direct

First COVID-19 outpatient study based on risk stratification and early antiviral treatment at the beginning of the disease. Low-dose hydroxychloroquine combined with zinc and azithromycin was an effective therapeutic approach against COVID-19. Significantly reduced hospitalisation rates in the treatment group. Reduced mortality rates in the treatment group. https://web.archive.org/web/20201117161908/https://www.sciencedirect.com/science/article/pii/S0924857920304258

The post COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study – Science Direct appeared first on Evidence Not Fear.

Leave a Reply

Your email address will not be published.